The Impact of Different Malaria Drugs in Curing Malaria Within the Ghanaian Populace: A Case Study of Sekondi-Takoradi

Abstract

Pharmaceutical companies are industries who engage in Research and Developments (R&D) to evolve new and improved therapies (drugs) to provide an efficient cure to individuals in the society. This research examines the impact of some selected malaria drugs on the lives of category of individuals (children, adults and the aged). The main objective is to know the impact of some selected malaria drugs on children, adults and the aged, to determine the affordability of malaria drugs and to know the efficacy rate of the selected malaria drugs among children, adults and the aged.The study population comprise of Sekondi-Takoradi of which 60 samples were drawn. A simple random sample technique was used in selecting the samples with the help of questionnaire as the main instrument. Preliminary analysis made use of descriptive statistics tools such as bar chart, pie chart and frequency tables. Analysis of variance (ANOVA) was used as tool for statistical inference. A combination of statistical software (SPSS and Minitab) and other software such as Microsoft Excel were used during data processing.The research results indicated that the ability of the selected malaria drugs to cure malaria disease is well appreciated; meaning that it has a positive impact on the lives of individuals. It was also known that the prices of the malaria drugs are moderate. The hypothesis claim (H_o) was accepted meaning if the drug cures malaria disease among children, it can also cure malaria disease among adults and the aged.The study recommends that pharmaceutical industries should engage in more research and developments (R&D) to bring out antimalarial drugs that “if all things been equal” can have a perfect relation in curing malaria disease among categories of individuals.

Keywords: Pharmaceutical companies, Research and Development, Individuals(children,adult and aged),Simple Random Sample, ANOVA, Afordability, Efficacy rate